Significant movement in price has been observed in Cohance Lifesciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Cohance Lifesciences Limited has submitted their response.
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BSE and NSE wrote to Cohance Lifesciences on April 29, 2026, seeking clarification on unusual price movement in the company's equity shares. The company responded confirming it has disclosed all information and events as required under SEBI Listing Regulations, including the outcome of a Board Meeting held on April 27, 2026. The company stated there is no other undisclosed information or event that may have caused the price movement. This is a standard regulatory clarification letter in response to exchange surveillance.
The clarification is essentially a 'no news' response — the company has no new material information to explain the price movement, which may disappoint traders looking for a catalyst. The stock price move remains technically unexplained from a disclosure standpoint.